1. Home
  2. Our Firm
  3. News
  4. Guggenheim Securities Announces Hiring of Barry Blake to Expand Its Healthcare Investment Banking Group

Our Firm

June 12, 2014

Guggenheim Securities Announces Hiring of Barry Blake to Expand Its Healthcare Investment Banking Group

NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, today announced the hiring of Barry Blake as a Senior Managing Director. Mr. Blake will focus on advising healthcare services companies and will commence work at Guggenheim in September 2014.

“We are very pleased to welcome Barry to the team,” said Mark Van Lith, Head of Investment Banking at Guggenheim Securities. “Barry is a trusted adviser to his clients. Barry’s strong relationships and deep sector expertise will contribute meaningfully to our healthcare franchise.”

Most recently, Mr. Blake was the Head of Global Healthcare Mergers and Acquisitions for Citigroup. Prior to that, he was in the M&A and Healthcare groups at JP Morgan and Lehman Brothers.

Mr. Blake has extensive relationships and experience in healthcare services. His recent transaction experience includes: Express-Scripts acquisition of Medco, Amsurg's acquisition of Sheridan Healthcare, the sale of Rehabcare Group to Kindred Healthcare, and Labcorp's acquisition of Genzyme Genetics.

Mr. Blake received his BS from Hendrix College and his MBA from Tuck School of Business.


About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $210 billion in assets under management. The firm provides asset management, investment banking and capital markets services, insurance services, institutional finance and investment advisory solutions to institutions, governments and agencies, corporations, investment advisors, family offices and individuals. Guggenheim Partners is headquartered in New York and Chicago and serves clients around the world from more than 25 offices in eight countries. For more information about Guggenheim Partners, visit www.guggenheimpartners.com.


Media Contacts

Thomas S. Mulligan
Sitrick And Company
310.367.6567
thomas_mulligan@sitrick.com

Terry Fahn
Sitrick And Company
310.788.2850
terry_fahn@sitrick.com



October 05, 2020

Debjit Chattopadhyay Joins Guggenheim Securities as Senior Biotech Analyst

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Debjit Chattopadhyay will join the firm in December as a Managing Director and Senior Biotech Analyst as part of the Healthcare Equity Research team. Dr. Chattopadhyay’s research focus will be gene therapy and rare diseases.

Read More

October 05, 2020

Guggenheim Securities Hires Cleantech Expert Jonathan Silver to Expand Sustainability Effort

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Jonathan Silver has joined the firm as a Senior Advisor to help lead the firm’s sustainability practice. Mr. Silver will advise the firm’s clients on their sustainability strategies, investments, and capital plans.

Read More

October 05, 2020

Guggenheim Securities Hires Richard Saltzman to Expand Private Capital Advisory Business

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Richard Saltzman will join the firm as a Managing Director to expand its private capital advisory business and will focus on secondary advisory. Mr. Saltzman will commence work at Guggenheim in December.

Read More



© 2020 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.